AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Range Resources: Piper Sandler Maintains Neutral Rating, PT Down to $39 from $41
ByAinvest
Thursday, Aug 14, 2025 10:36 am ET1min read
Range Resources: Piper Sandler Maintains Neutral Rating, PT Down to $39 from $41
In a recent update, Piper Sandler has maintained its neutral rating on Range Resources Corporation (NYSE: RRC) but has lowered its price target (PT) from $41 to $39. This adjustment comes following the company's second-quarter earnings report and the latest analyst ratings [1].Piper Sandler's revised PT reflects the company's performance and the broader market sentiment. Despite a 1.8% increase in shares owned by Charles Schwab Investment Management Inc. in the first quarter, the overall institutional ownership stands at 98.93%, indicating a significant interest from major investors [1].
Analysts have mixed opinions on Range Resources, with a consensus rating of "Hold" and an average price target of $43.37. Mizuho, for instance, has increased its price objective to $48.00, while UBS Group and Royal Bank of Canada have set their targets at $42.00 and $45.00, respectively [1].
Range Resources reported earnings per share (EPS) of $0.66 for the quarter, beating analyst estimates of $0.65. The company also announced a quarterly dividend of $0.09, representing a $0.36 annualized dividend and a dividend yield of 1.1% [1].
The company's focus on natural gas exploration and production in the Appalachian region has been a key driver of its performance. However, the recent delay in clinical trials by Vicarious Surgical Inc. (NYSE: RBOT), a company in the surgical robotics sector, has had a ripple effect on the broader market sentiment [2].
Investors should keep a close eye on Range Resources' future earnings reports and any strategic updates from the company. The lowered PT by Piper Sandler serves as a reminder of the potential risks and uncertainties in the energy sector, particularly in the face of fluctuating oil prices and geopolitical tensions.
References:
[1] https://www.marketbeat.com/instant-alerts/filing-range-resources-corporation-nyserrc-shares-purchased-by-charles-schwab-investment-management-inc-2025-08-13/
[2] https://za.investing.com/news/analyst-ratings/piper-sandler-lowers-vicarious-surgical-stock-price-target-on-delayed-clinical-use-93CH-3836983
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet